MELBOURNE HEALTH

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: -

Established: 1848-01-01

Employees: -

Market Cap: -

Website: http://www.mh.org.au/

Clinical Trials

REscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2

Phase 1

Not yet recruiting

Conditions: Poor Graft Function
Aplastic Anemia Idiopathic

Interventions: Drug: Ruxolitinib (JAKAVI®)
Drug: Eltrombopag (Revolade®)

First Posted Date: 2024-09-23

Last Posted Date: 2024-09-23

Lead Sponsor: Melbourne Health

Target Recruit Count: 20

Registration Number: NCT06607367

Locations: 🇦🇺
The Royal Melbourne Hospital, Parkville, Victoria, Australia

National Robotics-Assisted Radical Prostatectomy Database

Recruiting

Conditions: Oncological Outcomes
Prostate Cancer
Learning Curve
Robotic-assisted Radical Prostatectomy
Patient Reported Outcome Measures
Database
Surgical Outcomes

First Posted Date: 2024-02-28

Last Posted Date: 2024-08-26

Lead Sponsor: Melbourne Health

Target Recruit Count: 10000

Registration Number: NCT06279260

Locations: 🇦🇺
Ballarat Health, Ballarat, Victoria, Australia
🇦🇺
Barwon health, Geelong, Victoria, Australia
🇦🇺
Austin Healthcare, Melbourne, Victoria, Australia

and more 5 locations

Evaluating the Safety and Efficacy of Telemedicine Neurology Assessments on a Mobile Stroke Unit

Not Applicable

Recruiting

Conditions: Intracerebral Hemorrhage
Ischemic Stroke

Interventions: Other: In-Person Assessment by an Onboard Neurologist
Other: Telemedicine Assessment by Remote Neurologist

First Posted Date: 2023-08-14

Last Posted Date: 2023-09-21

Lead Sponsor: Melbourne Health

Target Recruit Count: 270

Registration Number: NCT05991310

Locations: 🇦🇺
Royal Melbourne Hospital Mobile Stroke Unit, Melbourne, Victoria, Australia

Electroconvulsive Therapy and Concomitant Lithium in Depressive Disorder: A Pilot Study

Early Phase 1

Active, not recruiting

Conditions: Depressive Disorder

Interventions: Drug: Lithium

First Posted Date: 2023-06-28

Last Posted Date: 2023-08-01

Lead Sponsor: Melbourne Health

Target Recruit Count: 20

Registration Number: NCT05923476

Locations: 🇦🇺
Hospital, Melbourne, Victoria, Australia

Contactless Vital Signs Measurement Study (CVMS)

Recruiting

Conditions: Vital Signs
Inpatients
Hospital-at-home

Interventions: Device: Validation of the accuracy of a combined oximeter, thermometer and heart rate measurement device

First Posted Date: 2023-06-02

Last Posted Date: 2023-06-06

Lead Sponsor: Melbourne Health

Target Recruit Count: 30

Registration Number: NCT05886686

Locations: 🇦🇺
Royal Melbourne Hospital, Melbourne, Victoria, Australia

Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes

Phase 2

Active, not recruiting

Conditions: Type 1 Diabetes
Diabetes Mellitus, Type 1

Interventions: Drug: Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®)
Drug: Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride)

First Posted Date: 2023-02-23

Last Posted Date: 2024-04-10

Lead Sponsor: Melbourne Health

Target Recruit Count: 62

Registration Number: NCT05742243

Locations: 🇦🇺
Queensland Children's Hospital, South Brisbane, Queensland, Australia
🇦🇺
The Royal Melbourne Hospital, Parkville, Victoria, Australia
🇦🇺
The Royal Children's Hospital, Parkville, Victoria, Australia

and more 3 locations

A Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma

Early Phase 1

Recruiting

Conditions: Glioma

Interventions: Procedure: Biopsy
Procedure: Surgery (maximal resection)

First Posted Date: 2022-10-13

Last Posted Date: 2024-06-10

Lead Sponsor: Melbourne Health

Target Recruit Count: 15

Registration Number: NCT05577416

Locations: 🇦🇺
Royal Melbourne Hospital, Melbourne, Victoria, Australia

Protocol for CAMUS Nurse Delphi Study

Conditions: Perioperative/Postoperative Complications
Urologic Diseases

First Posted Date: 2022-03-09

Last Posted Date: 2022-10-17

Lead Sponsor: Melbourne Health

Target Recruit Count: 250

Registration Number: NCT05272592

Locations: 🇦🇺
The Royal Melbourne Hospital, Melbourne, Victoria, Australia

Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

Phase 1

Recruiting

Conditions: Non-hodgkin Lymphoma
Plasma Cell Myeloma
Leukemia, Myeloid, Acute
Leukemia, Lymphoblastic, Acute, L2
Myelodysplastic Syndromes
Leukemia, Lymphoblastic, Acute, L1

Interventions: Drug: Venetoclax
Drug: Fludarabine
Drug: Cyclophosphamide

First Posted Date: 2021-08-13

Last Posted Date: 2023-08-01

Lead Sponsor: Melbourne Health

Target Recruit Count: 18

Registration Number: NCT05005299

Locations: 🇦🇺
Melbourne Health, Melbourne, Victoria, Australia

Protocol for CAMUS Delphi Study

Conditions: Complications; Urogenital, Postprocedural

Interventions: Other: Comprehensive questionnaire

First Posted Date: 2021-07-26

Last Posted Date: 2022-10-17

Lead Sponsor: Melbourne Health

Target Recruit Count: 750

Registration Number: NCT04976946

Locations: 🇦🇺
The Royal Melbourne Hospital, Melbourne, Australia

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy